CRP and metabolic dysfunction-associated steatotic liver disease: We observed a statistically significant improvement of several biochemical indices evaluated in the NAFLD group at the end of treatment in comparison to the baseline: ALT, insulinemia, HOMA-IR, CRP, tumor necrosis factor (TNF)-α (Figure 2) (p < 0.05).